I agree that this site is using cookies. You can find further informations here.
X
Sahin, Ayguen
7  results:
Search for persons X
?
1

Development of third generation anti-EGFRvIII chimeric T ce..:

Sahin, Ayguen ; Sanchez, Carlos ; Bullain, Szofia...
PLOS ONE.  13 (2018)  7 - p. e0199414 , 2018
Link: https://doi.org/10.1371/..
 
?
2

CT322, a VEGFR-2 antagonist, demonstrates anti-glioma effic..:

Waters, J. Dawn ; Sanchez, Carlos ; Sahin, Ayguen...
Journal of Neuro-Oncology.  110 (2012)  1 - p. 37-48 , 2012
Link: https://doi.org/10.1007/..
 
?
3

Genetically engineered T cells to target EGFRvIII expressin..:

Bullain, Szofia S. ; Sahin, Ayguen ; Szentirmai, Oszkar...
Journal of Neuro-Oncology.  94 (2009)  3 - p. 373-382 , 2009
Link: https://doi.org/10.1007/..
 
?
4

CT322, a VEGFR-2 antagonist, demonstrates anti-glioma effic..:

Waters, J. Dawn ; Sanchez, Carlos ; Sahin, Ayguen...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
5

Suppression of Human Glioma Xenografts with Second-Generati..:

Kong, Seogkyoung ; Sengupta, Sadhak ; Tyler, Betty...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
6

Genetically engineered T cells to target EGFRvIII expressin..:

Bullain, Szofia S ; Sahin, Ayguen ; Szentirmai, Oszkar...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730985.  , 2009
Link: http://www.ncbi.nlm.nih...
 
?
7

Development of third generation anti-EGFRvIII chimeric T ce..:

Ayguen Sahin ; Carlos Sanchez ; Szofia Bullain...
http://europepmc.org/articles/PMC6033533?pdf=render.  , 2018
Link: https://doi.org/10.1371/..
 
1-7